246 related articles for article (PubMed ID: 31301214)
21. Secreted frizzled-related protein 4 expression is positively associated with responsiveness to cisplatin of ovarian cancer cell lines in vitro and with lower tumour grade in mucinous ovarian cancers.
Saran U; Arfuso F; Zeps N; Dharmarajan A
BMC Cell Biol; 2012 Oct; 13():25. PubMed ID: 23039795
[TBL] [Abstract][Full Text] [Related]
22. Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy.
Ghoshal A; Ghosh SS
Mol Cell Biochem; 2016 Jul; 418(1-2):119-35. PubMed ID: 27334754
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic demethylation of sFRPs, with emphasis on sFRP4 activation, leading to Wnt signalling suppression and histone modifications in breast, prostate, and ovary cancer stem cells.
Deshmukh A; Arfuso F; Newsholme P; Dharmarajan A
Int J Biochem Cell Biol; 2019 Apr; 109():23-32. PubMed ID: 30710752
[TBL] [Abstract][Full Text] [Related]
24. Secreted frizzled-related protein 4 exerts anti-atherosclerotic effects by reducing inflammation and oxidative stress.
Zhang J; Yang Z; Liang Z; Wang M; Hu C; Chang C; Shi L; Ji Q; Liu L
Eur J Pharmacol; 2022 May; 923():174901. PubMed ID: 35364070
[TBL] [Abstract][Full Text] [Related]
25. Wnt antagonist, secreted frizzled-related protein 4 (sFRP4), increases chemotherapeutic response of glioma stem-like cells.
Warrier S; Balu SK; Kumar AP; Millward M; Dharmarajan A
Oncol Res; 2013; 21(2):93-102. PubMed ID: 24406045
[TBL] [Abstract][Full Text] [Related]
26. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells.
He B; Lee AY; Dadfarmay S; You L; Xu Z; Reguart N; Mazieres J; Mikami I; McCormick F; Jablons DM
Cancer Res; 2005 Feb; 65(3):743-8. PubMed ID: 15705870
[TBL] [Abstract][Full Text] [Related]
27. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
[TBL] [Abstract][Full Text] [Related]
28. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis.
Surendran K; Schiavi S; Hruska KA
J Am Soc Nephrol; 2005 Aug; 16(8):2373-84. PubMed ID: 15944336
[TBL] [Abstract][Full Text] [Related]
29. Interference of miR-943-3p with secreted frizzled-related proteins4 (SFRP4) in an asthma mouse model.
Shen J; Zhao J; Ye QY; Gu XD
Cell Tissue Res; 2019 Oct; 378(1):67-80. PubMed ID: 31101982
[TBL] [Abstract][Full Text] [Related]
30. The evil axis of obesity, inflammation and type-2 diabetes.
Das A; Mukhopadhyay S
Endocr Metab Immune Disord Drug Targets; 2011 Mar; 11(1):23-31. PubMed ID: 21348821
[TBL] [Abstract][Full Text] [Related]
31. SFRP4 Is a Negative Regulator of Ovarian Follicle Development and Female Fertility.
Zamberlam G; Lapointe E; Abedini A; Rico C; Godin P; Paquet M; DeMayo FJ; Boerboom D
Endocrinology; 2019 Jul; 160(7):1561-1572. PubMed ID: 30942852
[TBL] [Abstract][Full Text] [Related]
32. Transgenic mice overexpressing secreted frizzled-related proteins (sFRP)4 under the control of serum amyloid P promoter exhibit low bone mass but did not result in disturbed phosphate homeostasis.
Cho HY; Choi HJ; Sun HJ; Yang JY; An JH; Cho SW; Kim SW; Kim SY; Kim JE; Shin CS
Bone; 2010 Aug; 47(2):263-71. PubMed ID: 20472109
[TBL] [Abstract][Full Text] [Related]
33. The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus.
Liu LB; Chen XD; Zhou XY; Zhu Q
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29789397
[TBL] [Abstract][Full Text] [Related]
34. Human epicardial adipose tissue-derived and circulating secreted frizzled-related protein 4 (SFRP4) levels are increased in patients with coronary artery disease.
Ji Q; Zhang J; Du Y; Zhu E; Wang Z; Que B; Miao H; Shi S; Qin X; Zhao Y; Zhou Y; Huang F; Nie S
Cardiovasc Diabetol; 2017 Oct; 16(1):133. PubMed ID: 29037197
[TBL] [Abstract][Full Text] [Related]
35. Secreted frizzled-related protein 4 and its implications in cancer and apoptosis.
Pohl S; Scott R; Arfuso F; Perumal V; Dharmarajan A
Tumour Biol; 2015 Jan; 36(1):143-52. PubMed ID: 25501511
[TBL] [Abstract][Full Text] [Related]
36. Adipose- and muscle-derived Wnts trigger pancreatic β-cell adaptation to systemic insulin resistance.
Kozinski K; Jazurek M; Dobrzyn P; Janikiewicz J; Kolczynska K; Gajda A; Dobrzyn A
Sci Rep; 2016 Aug; 6():31553. PubMed ID: 27527335
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells.
Perumal V; Pohl S; Keane KN; Arfuso F; Newsholme P; Fox S; Dharmarajan A
Exp Cell Res; 2016 Feb; 341(2):218-24. PubMed ID: 26868304
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis.
Bayle J; Fitch J; Jacobsen K; Kumar R; Lafyatis R; Lemaire R
J Invest Dermatol; 2008 Apr; 128(4):871-81. PubMed ID: 17943183
[TBL] [Abstract][Full Text] [Related]
39. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.
Esser N; Legrand-Poels S; Piette J; Scheen AJ; Paquot N
Diabetes Res Clin Pract; 2014 Aug; 105(2):141-50. PubMed ID: 24798950
[TBL] [Abstract][Full Text] [Related]
40. Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes.
Abderrahmani A; Yengo L; Caiazzo R; Canouil M; Cauchi S; Raverdy V; Plaisance V; Pawlowski V; Lobbens S; Maillet J; Rolland L; Boutry R; Queniat G; Kwapich M; Tenenbaum M; Bricambert J; Saussenthaler S; Anthony E; Jha P; Derop J; Sand O; Rabearivelo I; Leloire A; Pigeyre M; Daujat-Chavanieu M; Gerbal-Chaloin S; Dayeh T; Lassailly G; Mathurin P; Staels B; Auwerx J; Schürmann A; Postic C; Schafmayer C; Hampe J; Bonnefond A; Pattou F; Froguel P
Diabetes; 2018 Jul; 67(7):1310-1321. PubMed ID: 29728363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
